Evidence map›Paper›PMID 37661711›Full record

GuidelineCephalalgia : an international journal of headache2023

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension.

Susan P Mollan, Clare L Fraser, Kathleen B Digre, Hans-Christoph Diener, Richard B Lipton, Marianne Juhler, Neil R Miller, Patricia Pozo-Rosich, Mansoureh Togha, Kristian Brock and 6 more

Open access · hybridAbstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Cephalalgia : an international journal of headache, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 11 countries.

Susan P MollanNeuro-ophthalmology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, Birmingham, UK.ORCID 0000-0002-6314-4437
Clare L FraserSave Sight Institute, University of Sydney, Sydney, NSW, Australia.
Kathleen B DigreNeuro-ophthalmology Division, John A. Moran Eye Center, University of Utah, Salt Lake City, USA.
Hans-Christoph DienerInstitut für Medizinische Informatik, Biometrie undEpidemiologie (IMIBE), Medizinische Fakultät der Universität Duisburg-Essen, Essen, Germany.ORCID 0000-0002-6556-8612
Richard B LiptonThe Saul R. Korey Department of Neurology, and the Montefiore Headache Center, Albert Einstein College of Medicine, Bronx, New York, USA.ORCID 0000-0003-2652-2897
Marianne JuhlerDepartment of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Neil R MillerWilmer Eye Institute and Departments of Ophthalmology, Neurology, and Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Patricia Pozo-RosichHeadache Unit, Neurology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.ORCID 0000-0003-0796-4702
Mansoureh ToghaHeadache Department, Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9368-6835
Kristian BrockCancer Research Clinical Trials Unit, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Marc J DinkinDepartment of Ophthalmology, Weill Cornell Medical College, NY Presbyterian Hospital, New York, New York, USA.
Carmen K M ChanDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Cristina TassorelliUnit of Translational Neurovascular Research, IRCCS Mondino Foundation, 27100, Pavia, Italy.ORCID 0000-0003-1513-2113
Alex J SinclairTranslational Brain Science, Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Gisela M TerwindtDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Rigmor H JensenDepartment of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DKAlbert Einstein College of Medicine · USCancer Research UK Clinical Trials Unit · GBChinese University of Hong Kong · HKCornell University · USInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DEJohns Hopkins University · USLeiden University Medical Center · NLQueen Elizabeth Hospital Birmingham · GBSina Hospital · IRThe University of Sydney · AUUniversitat Autònoma de Barcelona · ESUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Pavia · ITUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society

Indexed as

HeadachePseudotumor CerebriControlled Clinical Trials as TopicHumansdrugGuidelinesheadacheIdiopathic intracranial hypertensionlumbar puncturepapilloedemaPseudotumor cerebriraised intracranial pressureRandomised control trialvision

Identifiers

PMID37661711
OpenAlexW4386406868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.